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INTRODUCTION
     ‘Relief of pain is purchased always at a price’
-Ralph waters
        ‘For all the happiness mankind can gain is not in pleasure but in rest 
from pain’
-John Dyrden.
       The aim of anaesthesiology as a science is the removal of pain 
temporarily, started initially with pain relief for surgeries, extending now on 
to postoperative pain relief, chronic pain and cancer pain.
        Spinal anaesthesia plays a major role in alleviating pain 
intraoperatively extending sometime into postoperative period also.
         The entry of Corning’s needle in 1885 into subarachnoid space paved 
the way for the greatest leap into the spinal anaesthesia. His works “Be the 
density of this observation, what it may have seemed to me on the whole, 
worth recording”. This opened the prologue for the work “spinal 
anaesthesia”.
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       Cocaine was the drug first used experimentally in dogs. In men the first 
spinal anaesthesia was conducted by “August Bier” on 16 August 1898 with 
cocaine 3ml as 0.5% solution followed by Matas in America and Tuffier in 
France.
        Spinal anesthesia for caesarean section has always enjoyed popularity 
as it eliminates the complication of pulmonary aspiration and avoids the 
problem of difficult airway observed with general anaesthesia. The other 
advantages of this technique are its simplicity, rapidity in onset and 
dependability. 
        The demonstration of opiate receptors in the substantia gelatinosa of 
spinal cord (Yaksh and Rudy 1976) has created interest in the intrathecal 
administration of opiates.
        The use of Intrathecal morphine for providing postoperative pain relief 
in caesarean section was started in the year 1988 by Ezzaz Aboulesish et al.
       The advantages of neuraxial opioids over neuraxial local anaesthetics 
are that, it produces prolonged, intense, selective, segmental analgesia 
without motor blockade and sympathetic dysfunction.
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Opiods and local anesthetics administered together have a potent 
synergistic analgesic effect. Intrathecal opioids enhance analgesia from sub 
therapeutic dose of local anaesthetic and make it possible to achieve 
successful spinal anaesthesia using otherwise inadequate doses of local 
anaesthetic.
Hence, the present study has been undertaken to combine “sufentanil” 
a recently introduced opioid in Indian market and “bupivacaine”, a long 
acting local anaesthetic for intrathecal administration to provide anaesthesia 
for caesarean section.
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AIM OF THE STUDY
1. To evaluate the effect of intrathecal sufentanil in improving the 
quality of anaesthesia with 0.5% hyperbaric bupivacaine in low dose 
for lower segment caesarean section.
2. To evaluate the efficacy of intrathecal sufentanil in providing 
postoperative pain relief for lower segment caesarean section.
3. To assess the duration of pain relief.
4. To assess the incidence of side effects
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ANATOMY OF SUBARACHNOID SPACE 
The  vertebral  column  consists  of  7  cervical,  12  thoracic,  5 
lumbar,  5  sacral  and  4-5  coccygeal  vertebrae.The  sacral  and 
Coccygeal vertebrae are fused in adult life.
The vertebral columns has 4 curvatures.Thoracic and sacral are 
primary  curvatures  and concave  anteriorly.Cervical  and lumbar  are 
secondary curvatures and convex anteriorly.When the spine is fully 
flexed  the  cervical  and  lumbar  curvatures  are  obliterated.During 
pregnancy there will be an exaggerated lumbar lordosis.
There are 31 pairs of spinal nerves, 8 cervical, 12 thoracic, 5 
sacral  and  1  coccygeal.  Subarachnoid  space  lies  between  the 
arachnoid  and  piamater.  It  contains  cerebrospinal  fluid  and  it 
communicates with the ventricular system at the base of the brain.
                     CONTENTS
a. Spinal nerve roots
B.Cerebrospinal fluid
C.Denticulate ligaments
D.Spongy reticulum fibres connecting the Pia to Arachnoid and
E.Blood vessels
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Applied anatomy
Pregnancy reduces anaesthetic requirements both during 
regional as well as general anaesthesia.
During spinal / epidural anaesthesia less local anaesthetics are 
required to produce a given level of blockade.
The reduced anesthetic requirements are due to
1. Mechanical effects of gravid uterus increasing the intra 
abdominal pressure, causing epidural venous engorgement and a 
reduction of both the epidural and subarachnoid spaces.
2. Nerve fibres have increased sensitivity to local anaesthetic 
due to the increase in progesterone level.
Sub arachnoid block means privation of senses not necessarily 
implying loss of consciousness.
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APPLIED ANATOMY OF VERTEBRAL CANAL
Vertebral  canal  extends  from  the  foramen  magnum  to  the  sacral 
hiatus, it protects the spinal cord.
Vertebral  column  is  formed  by  7  –  cervical,  12-  vertebral,  12  – 
thoracic, 5-lumbar, 5- sacral and 4-coccygeal vertebrae.
Each vertebra is composed of a ‘body’ separated from the adjacent 
vertebra by the intervertebral disc and ‘vertebral arch’ formed by pedicles 
and laminae, which surround and protect the cord laterally and posteriorly.
VERTEBRAL LIGAMENTS BOUNDING THE CANAL 
Supraspinous ligament passes longitudinally over the tips of spinous 
processes from C7 vertebra to the sacrum.
Interspinous ligament- connecting the two adjacent spinous processes 
together situated deep to the supraspinous ligament.
Ligamentum flavum extends from laminae to laminae and is 
composed of yellow elastic fibres. Half of the posterior wall is composed of 
the bony laminae and half by ligamentum flavum. They become 
progressively thicker from above downwards.
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Posterior longitudinal ligament is on posterior surface of bodies of vertebrae.
Anterior longitudinal ligament runs along the front of the vertebral bodies.
There are seven projections from these vertebral or neural arches. 
They are
1. Three muscular processes- two transverse and one spinous for 
the attachment and ligaments, and
2. Four articular processes- two upper and two lower – which in 
the lumbar region, prevent rotation by allowing limited flexion 
and extension between contiguous vertebrae.
Vertebral canal formed by these structures, has deficiencies 
posteriorly in the midline, called inter laminar foramina, which enlarges 
during flexion thereby aiding the passage of spinal needle. The direction of 
spinous processes determines the direction of the spinal needle.
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SPINAL CORD
It is the direct continuation of medulla oblongata extending from the 
upper border of atlas to first lumbar vertebra, below which there is leash of 
nerve roots termed cauda equine. Spinal nerves are 31 pairs totally. 
8- Cervical
12- Thoracic
5- Lumbar
5- Sacral
1- Coccygeal
Each of the spinal nerve is composed of anterior and posterior roots 
uniting at the level of inter vertebral foramina and form a nerve trunk. 
Membranes covering the spinal cord from without are dura mater, arachnoid 
mater and piamater. Dura and arachnoid end at S2 level. Piamater is closely 
applied to the spinal cord.
Blood supply
Blood supply is from the anterior spinal artery which is a branch of 
vertebral artery and also by a pair of posterior spinal arteries which arise 
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from the posterior inferior cerebellar arteries. There is no anastamosis 
between these arteries.
Venous channels
The spinal veins are arranged into anterior and posterior plexuses 
which drain into vertebral, lumbar and azygous veins.
Cerebrospinal fluid (CSF)
Cerebrospinal fluid is the ultra filtrate of plasma from choroid plexus 
of lateral ventricles, with a pH of 7.4.
The amount of cerebrospinal fluid in spinal canal is 75 ml with a 
pressure of 70-170mm of H2O) in lateral position.
It contains, 
20-40mg% of protein
45-80 mg% of sugar and 
0-5 lymphocytes/mm3 normally
An important factor that determines the spread of drug in CSF is the 
specific gravity of the drug in relation to that of CSF (barricity) whose 
specific gravity is 1.003-1.009. (Average 1.004). Hyperbaric solution is one 
which is denser than CSF at 370c.
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PHYSIOLOGY OF SUBARACHNOID BLOCK
Subarachnoid block implies temporary interruption of nerve 
transmission by injection of drugs into the subarachnoid space. The 
blockade of nerve fibres occurs in the order of temperature, pain, 
proprioception and lastly motor fibres.
Factors controlling the extent and duration of block
1. Specific gravity of the solution is the most important 
2. Position of the patient during and immediately after injection
3. Site of injection
4. Volume and concentration of the solution: increasing the dose 
and concentration prolongs the effect.
5. Patient factors like age, height, pregnancy and obesity.
Effects on cardiovascular system
The most important physiological response to spinal anaesthesia 
involves the cardiovascular system due to the sympathetic denervation. β 
fibres are more sensitive than A fibres causing a higher sympathetic block 
(zone of differential blockade ) resulting in vasodilatation and a fall in blood 
pressure especially if a substantial number of thoracic segments are blocked. 
Due to Bain bridge reflex, the fall in blood pressure is associated with 
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bradycardia. Blockade of cardiac sympathetic fibres from T1-T4 is an 
additional factor that causes bradycardia.
Effects on Respiratory system
Respiration is not depressed normally. High spinal anesthesia can 
cause paralysis of intercostal muscles, but resting tidal volume, maximum 
inspiratory volume and negative intrapleural pressure are not much altered. 
Expiratory muscles are more affected than inspiratory muscles. Hypoxia 
may accompany hypotension and is corrected by oxygen via face mask.
Metabolic and hormonal effects
Spinal anaesthesia blocks hormonal and metabolic responses to 
nociceptive stimuli arising from the operative site, thereby minimizing the 
rise in blood sugar, cortisol, catecholamines, renin and aldosterone release 
associated with the stress. Postoperative negative nitrogen balance and 
secretion of antidiuretic hormone are inhibited.
Hepatic and renal effects
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The hepatic blood flow decreases and is directly proportional to the 
decrease in blood pressure. There may be more of hepatic oxygen extraction. 
Renal blood flow is maintained by auto regulation and does not decrease till 
mean arterial pressure falls below 50mm of Hg.
Thermoregulation and shivering
Hypothermia results from heat loss to the cold environment due to 
sympathetic paralysis caused by the subarachnoid block
Genitourinary systems
Sphincters of the urinary bladder are not relaxed, and the tone of 
ureters is not greatly altered. Penis is often engorged and flaccid due to 
paralysis of nervi-erigentes (S2, 3). Post spinal retention of urine may be 
moderately prolonged as L2 and L3 contain small autonomic fibers and their 
paralysis lasts longer than that of the larger sensory and motor fibers. 
Uterine tone is unchanged in pregnancy. In the absence of hypotension, 
spinal anaesthesia has got no effect on the progress of labor and uterine 
blood flow.
Gastrointestinal effects
Preganglionic fibres from T5 to L4 are inhibitory to the gut. So in 
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sympathetic blockade, the small intestine contracts with relaxed sphincters 
and peristalsis often remains normal. Handling of the viscera causes 
discomfort and bradycardia, since vagus is not blocked.
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 PHYSIOLOGICAL CHANGES DURING PREGNANCY
BODY CONSTITUENTS
Blood volume begins to increase in the first trimester and reaches 
50% above the non pregnant level in the third trimester. The red blood cell 
mass also rises steadily but relatively less than the total blood volume with a 
consequent reduction in hemoglobin concentration despite raised total 
hemoglobin content.
CARDIOVASCULAR FUNCTION
Cardiac output, myocardial contractility, heart rate and stroke volume 
are increased. The increase in cardiac output starts in the first trimester. 
Arteriovenous oxygen content difference is reduced until the final trimester. 
Systemic vascular resistance is decreased. No change occurs in pulmonary 
arterial pressure during pregnancy. Blocking the autonomic nervous system 
may result in dramatic decrease in systemic arterial pressure during 
pregnancy, suggesting a chronically active sympathetic tone. 
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RESPIRATORY FUNCTION
Respiratory tract is edematous due to capillary engorgement. 
Functional residual capacity is decreased. Although the enlarging uterus 
causes elevation of diaphragm, total lung capacity and vital capacity remain 
unchanged due to compensatory increase in the antero-posterior and 
transverse diameters of chest. The minute volume increases in late 
pregnancy due to increase in tidal volume and respiratory rate with an 
increase in oxygen consumption.
Average changes from non pregnant value
Minute ventilation +50  %
Tidal volume +40 %
Breathing rate -10
PaO2 +10 mm of Hg
PaCO2 -10 mm of Hg
pH No change
Total lung capacity No change
Vital capacity No change
FRC -20%
Expiratory reserve volume -20%
Residual volume -20%
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Airway resistance -35%
Oxygen consumption +20%
BMR +15 – 20 %
RENAL FUNCTION 
Changes in renal function are mainly due to increased levels of 
ACTH, ADH, aldosterone, cortisol and thyroid hormone. Glomerular 
filtration rate starts increasing early and remains at about 40% above the non 
pregnant level by midpregnancy. Renal plasma flow also increases as much 
as 50% and peaks by the end of the second trimester, remaining high until 
term.
GASTRO INTESTINAL FUNCTION
Gastro intestinal motility decreases due to a direct effect of 
progesterone and also by an inhibitory effect of progesterone on plasma 
motilin. The lower esophageal sphincter tone is diminished.
HEPATIC FUNCTION
There are no gross morphological changes but functional changes are 
present in the liver. The plasma cholinesterase level is decreased 
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significantly as early as the first trimester and remains low until delivery.
COAGULATION AND FIBRINOLYTIC FUNCTIONS
Plasma levels of factors VII, X, XII and fibrinogen increase during 
pregnancy, leading to a hypercoagulable state.
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EVALUATION OF THE NEONATE
The importance of assessment of the neonate immediately after the 
birth is to promptly identify the depressed infants, who require active 
resuscitation. As a guide to identify and to treat the depressed neonate, 
Apgar score is used. 
APGAR SCORE
Virginia Apgar of New York City described a system whereby the 
condition of a neonate can be assessed at one minute and five minutes after 
delivery. The Apgar score has been shown to correlate well with acid-base 
measurements performed immediately after birth.
SL.I. NO SIGNS SCORES
0 1 2
1 HEART RATE Absent <100 / min >100 / min
2 RESPIRATORY EFFORT Absent
Slow, 
irregular Crying
3 REFLEX IRRITABILITY No response Grimace Crying
4 MUSCLE TONE Limp Hypotonia Active
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5 COLOR Pale; cyanotic
Body pink, 
extremities 
cyanotic
Pink
TIME FOR SUSTAINED RESPIRATION
The time interval between delivery and the establishment of sustained 
respiration has been used to identify the depressed neonate. A time for 
sustained respiration greater than 90 seconds indicates a depressed neonate 
and correlates with Apgar score of 6 or less.
NEUROBEHAVIOURAL TESTING
Neurobehavioral testing is able to detect subtle or delayed effects of 
drugs administered during labour and delivery that are not appreciated by 
Apgar score. The testing evaluates neonate’s state of wakefulness, reflex 
(moro, rooting and sucking reflexes) response, muscle tone and response to 
sound.
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PHARMACOLOGY OF DRUGS
PHARMACOLOGY OF BUPIVACAINE
Bupivacaine is an amide linked local anesthetic. It is a hydrochloride 
salt of d (1)-1butyl 2’ 6’ pipecoloxylidide and is presented as a racemic 
mixture.
 It was synthesized by BO af Ekenstem.
 A first report of its use was published in 1963 by Telivuo.
 It is derived from mepivacaine and is a very stable compound and 
may be autoclaved repeatedly.
 pKa is 8.2. Heptane/ buffer partition co-efficient is 27.5
 Molecular weight is 288. Protein binding is 96%
AVAILABILITY
Ampoules: 0.5% bupivacaine hydrochloride 4ml
       0.5% bupivacaine hydrochloride with dextrose (heavy) 4ml
Vials        : 0.25%, 0.5% bupivacaine hydrochloride 20ml
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DOSAGE
Maximal dose: 3mg/Kg body weight
Uses:     
Spinal
Epidural
Caudal
Continuous epidural
Peripheral nerve block
ONSET TIME AND DURATION OF ACTION
SITE OF ACTION ONSET(minutes )
DURATION 
(minutes )
INTRATHECAL 5 180-240
EPIDURAL 15-20 165-225
NERVE BLOCKS 
e.g., Brachial plexus 
block
15-20 600
PHARMACOKINETICS
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Once injected intrathecally, it gets absorbed by the nerve rootlets and 
results in the desired effect. It is rapidly absorbed from the site of injection, 
but the rate of absorption depends on the vascularity at the site and presence 
of vasoconstrictors.
High lipid solubility of bupivacaine makes it easy for nerve and 
vascular tissue penetration.
80-95% of the absorbed bupivacaine binds to the plasma protein.
DISTRIBUTION 
Rapid distribution phase (α)
In this phase the drug is distributed to highly vascular region, t1/2 (α) 
being 2.7 minutes.
Slow disappearance phase (β)
In this phase the drug is distributed to equilibrating tissues, t1/2 (β) 
being 28 minutes.
Biotransformation and excretion phase (δ)
t1/2 (δ) being 3.5 hours, clearance is 0.47 litre/minute.
Biotransformation
It is by the liver. The N-dealkylated metabolite is pipecolyloxylidine.
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Excretion
It is through the kidneys. 4-10% of the drug is excreted unchanged in 
urine.
Mode of action
(a).Site of action
1. The Spinal nerve rootlet- fine nerve filaments having a 
large surface area are exposed to the local anaesthetic.
2. The posterior and lateral aspects of the spinal cord itself.
(b).Sodium channel blockade
They impede sodium ion access to the axon-interior by 
occluding transmembrane sodium channels thus denying the 
process of polarization and the axon remains polarized. It is a 
non- depolarization blockade.
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PHARMACODYNAMICS
It has got a longer duration of action but a slower onset.
Cardiovascular system
It reduces cardiac output by reducing the sympathetic tone, by 
slowing the heart rate and by reducing the venous return.
It produces a fall in arterial blood pressure but it is relatively slow and 
is seldom very profound.
It produces a fall in central venous pressure
It causes an increase in lower limb blood flow 
It causes a reduction in incidence of deep vein thrombosis
Respiratory system
Spinal blockade seldom, if ever, causes respiratory problems.
Gastrointestinal tract
There is increase in gastro intestinal motility and emptying of gastric 
contents is better.
Toxicity
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Toxicity is related to plasma level of unbound drug and more likely 
due to an inadvertent intravenous injection. Systemic toxicity – reactions 
primarily involve the central nervous system and the cardiovascular system. 
The blood level required to produce central nervous system toxicity is less 
than that required to produce circulatory collapse.
Central nervous system toxicity 
Initial symptoms include feeling of light headedness and dizziness, 
followed by visual and auditory disturbances. Objective signs are excitatory 
and include muscle twitching and tremors. Ultimately generalized tonic, 
clonic seizures occur.
Cardiovascular system toxicity
The rate of depolarization in fast conduction tissue of purkinjee fibres 
and ventricular muscle is decreased. The rate of recovery of bupivacaine 
induced block is slower than that of lignocaine. Extremely high 
concentration of the drug causes sinus bradycardia and cardiac arrest. 
R enantiomer is more toxic than S enantiomer
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PHARMACOLOGY OF SUFENTANIL
           Sufentanil is a thienyl analogue of fentanyl.The analgesic potency of 
sufentanil is 5 to 10 times of fentanyl which parallels the greater affinity of 
sufentanil for opioid receptors compared with that of fentanyl.
         It is a synthetic narcotic agonist.
   Availability
          Available in 1ml, 2ml, 5ml glass vials.Each ml contains
 50 micrograms of sufentanil
  Routes of administration
         -Intravenous; 1.Administation as primary anaesthetic agent with 100% 
oxygen.
                               2. Administration as an analgesic adjunct to nitrous  
oxide/oxygen
         -Epidural administration
         -Subarachnoid administration
Pharmacokinetics
      It is described as a 3 compartment model with an average distribution 
time of 0.72 minutes.
     Redistribution time of 13.7 minutes
     Elimination half life 148minutes.
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     Plasma  protein  binding  is  approximately  92.5%  and  80%  of  the 
administered dose is excreted in 24 hrs.
    The liver and intestine are the major sites of biotransformation 
    Sufentanil has immediate onset of action. A dose dependent attenuation of 
the sympathetic response to surgical stress has been demonstrated at i.v dose 
of 8-30 microgram/kg
   Peak plasma concentration of sufentanil administered epidurally is reached 
within 10mins and is 46 times lower than those after i.v administration. 
Pharmacodynamics
       Cardiovascular system
              Sufentanil has weak cholinergic activity hence should be used with 
caution in patients with cardiac arrhythmias
             It produces bradycardia by binding to M3 receptors. It slows AV 
node conduction and prolongs PR interval 
            Opioids may induce hypotension especially  in  hypovolaemic 
patients. Appropriate measures to maintain a stable arterial pressure should 
be taken.
      
 Respiratory system
             Respiratory depression is dose related and can be reversed by the 
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specific narcotic antagonist, Naloxone, but repeated dose of the antagonist 
may be necessary because the duration of respiratory depression may last 
longer than the opioid antagonist.
             Marked respiratory depression accompanies profound analgesia.
             It can persist in the post-operative period and if sufentanil has been 
given intravenously it can recur.
             Hyperventilation during anaesthesia may alter the patient’s response 
to CO2 thus affecting respiration post-operatively.
             The incidence and severity of early respiration with epidural 
administration may be less if adrenaline is added.
     Musculo skeletal system
             Induction of muscle rigidity, which may also involve the thoracic 
respiratory muscles, can occur but the risk may be reduced if intravenous 
injections are administered slowly.
     Central nervous system
             Sufentanil produces euphoria, sedation and miosis
     Gastrointestinal tract
             Sufentanil causes nausea, vomiting and biliary spasm
Adverse effects
      Respiratory depression
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              Various studies have showed that respiratory depression may occur 
after any opioid, irrespective of its route of administration
       Urinary retention
                Sufentanil is likely to interact with opioid receptors located in 
sacral  segments  of  spinalcord.This  in  turn  promotes  inhibition  of  sacral 
parasympathetic  outflow which  causes  detrusor  muscle  relaxation and an 
increase in maximum bladder capacity leading to urinary retention.
       Pruritus
                 Most common side effect is pruritis.The incidence is 0-100%.It 
may be generalized or localized to the face, neck and upper thorax.
      Nausea and vomiting
                 Intraoperative incidence is 30%.It may be due to the cephalad 
migration of the drug and subsequent interaction with opioid receptors in 
vascularised Area postrema.
     Hypotension
              Intrathecal pethidine and sufentanil cause hypotension and the 
mechanism is not known.
              This effect is mediated at the spinal level and hence neuraxial 
opioids are not an exemption from this effect. 
    Other effects 
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                Chest wall rigidity
                Apnoea
                Diaphoresis
                Emesis
                Dizziness
                Blurred vision
                Allergic reactions and asystole have been reported
Over dosage and treatment
           The over dosage of sufentanil manifest itself as an extension of its 
pharmacological actions.
                   Effects                                   Treatment
             Hypoventilation                       Oxygen therapy
             Severe resp.depression             Naloxone
             Hypotension                             Parentral fluid therapy
             Pruritus                                      Chlorpheneramine
Dosage
         1. Administration as primary anaesthetic agent with 100%Oxygen
                                                      Adult                            Children      
                Initial dose              :  8-30mic/kg                   10-25mic/kg
                Maintenance dose   : 0.5-0.75mic/kg                0.5-0.75mic/kg
35
         2. Administration as an analgesic adjunct to Nitrous oxide/Oxygen
                Initial dose               : 1-8mic/kg
                 Maintenance dose   : 0.1-0.5mic/kg
         3.  Epidural  administration  for  post  .op.  pain  relief:  30-50mic 
for 4-6 hrs
         4. Labour analgesia (along with bupivacaine):15-30mic
         5. Subarachnoid block: 2.5-10mic
Interactions
          Barbiturates, benzodiazepines.neuroleptics, halogenic gases and other 
non  selective  CNS  depressants  may  potentiate  the  depressive  effects  of 
sufentanil
         Mono-amine oxidase inhibitors must be discontinued 2 weeks prior to 
the administration of sufentanil.
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OPIATE SYSTEM
“Among the remedies which it has pleased almighty god to give to man 
to relieve his sufferings, none is so universal and efficacious as opium”.
-Sydenham 1680.
The term opioid refers to all exogenous substances natural and 
synthetic that binds specifically to any of the several sub population of 
opioid receptors.
Opioid receptors: discovered by Pert and Snyder in 1974.
Types: Mu, Kappa, Sigma, Delta and Epsilon.
Distribution: Widespread areas in brainstem and spinal cord. 
1. Areas associated with emotion – amygdala and limbic system
2. Area postrema
3. Along the course of pain pathways in medial thalamus
4. Spinal cord – marginal zone
- substantia gelatinosa
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RECEPTOR EFFECT AGONIST ANTAGONIST
μ 1 Supraspinal analgesia Meptazinol β- endorphin
Naloxone, 
pentazocaine
μ 2
Hyperventilation,
Bradycardia,
Physical 
dependence,
Euphoria,Ileus
Morphine,Pethidine,Fent
anyl,Sufentanil,Alfentanil Nalbhupine
δ Modulate μ activity Leu-enkephalin
Naloxone,
Metenkephali
n
К
Analgesia
Sedation
Hypoventilation
Miosis
Dynorphin
Pentazocine
Butorphanol
Buphrenorphine
Naloxone
∑
Dysphoria
Hypertonia
Tachycardia
Tachypnoea
Pentazocine
Ketamine Naloxone
Є
Stress induced 
alteration in 
nociception
Β-endorphin -
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INTRATHECAL NARCOTICS
‘NARCOTIC’ means a drug, which produces sleep or stupor. Opiate 
receptors were identified in the central nervous system in 1973 and 
1977.The endogenous Opioids were discovered by HUGHES et al in 1975 
and TSANG et al in 1976.Opioid receptors in spinalcord was demonstrated 
by LA MOTTE et al in 1976.In the same year, YAKHSH and RUDY, 
demonstrated analgesia in animals produced by spinally applied opioids. 
Intrathecal opioid was first used in man by WANG et al in 1979.Extradural 
opioids was first used by BEHAR et al in 1979
Opioid receptors are present in great concentration in dorsal horn of 
spinalcord.There are three types of μ(mu) К(kappa) δ(delta).Spinal opioids 
act mainly through μ receptors but kappa & delta also play a role.These 
drugs act by suppression of sensory input at REXED LAMINA ІІ & V of the 
dorsal horn in the substatia gelatinosa of spinalcord.It is recognized that 
opioids suppress nociceptive input at the spinal level by their action on the 
opioid receptors in the spinal cord by bypassing the blood and blood brain 
barrier. Small doses of opioids administered into the subarachnoid space 
provide profound and prolonged segmental analgesia. Numerous studies 
have shown that spinal opioids can provide profound post operative 
analgesia with less central and systemic adverse effects than opioids 
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administered systemically.
Predicted advantages of intrathecal opioid
1. Segmental analgesia with no motor loss.
2. No autonomic block with consequent absence of hypotension. 
3. Availability of larger number of drugs.
4. Existence of specific antagonist.
Factors affecting efficacy
Opioids differ in regard to their efficacy and side effect profile 
depending on whether they are hydrophilic or lipophilic. 
HYDROPHILIC:  Morphine
LIPOPHILIC: Alfentanil
   Fentanyl
   Sufentanil
   Meperidine
Lipophilic opioids diffuse quickly into epidural fat and venous plexus. 
Their action is characterized by rapid onset and shorter duration of action. 
Hydrophilic drugs like morphine diffuse slowly into the tissues and have 
long latencies.
Uses of Intrathecal narcotics
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Acute pain
1. Post operative pain 
2. Post traumatic pain
3. Other acute pain conditions
E.g: pancreatitis
Chronic pain
1. Malignancy
2. Non malignant chronic pain
For operative procedures
           Lower limb and lower abdominal surgeries
Side effects
1. Nausea and vomiting
2. Sedation
3. Itching
4. Urinary retention
5. Early or late respiratory depression
Less common side effects
41
1. Mental status changes
2. CNS excitation
3. Hyperalgesia
4. Herpes labialis virus reactivation 
5. Neonatal morbidity
6. Sexual dysfunction
7. Cardiac dysarrhythmias
8. Anaphylaxis
9. Thermoregulatory dysfunction
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DOSAGE OF INTRATHECAL OPIOIDS
DRUG DOSE DURATION(hrs)
Morphine 0.1-0.5mg 8-24
Meperidine 10-30mg 10-30
Diamorphine 0.05-0.1mg 20
Fentanyl <50mcg 2
Sufentanil <10mcg 2
FACTORS INCREASING THE RISK OF RESPIRATORY 
DEPRESSION
1. Repeated dose of opioids
2. IV sedative and concomitant use of narcotic and other respiratory 
depressants
3. Advanced age
4. Coexisting disease
5. Thoracic epidural placement
6. General anaesthesia
7. Increased intrathoracic pressure
8. Patient position
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Combination of local anesthetic with opioids for spinal anaesthesia:
The rationale for the combination of local anesthetic with opioids is 
that these two type of drugs eliminate pain by acting at different sites, the 
local anesthetic at the nerve axon and the opioid at the receptors in the spinal 
cord. Newer developments include increasing use of local anesthetic and 
opioids particularly in obstetric population. Opioids have been frequently 
used in association with local anesthetic in regional anaesthesia in order to 
obtain faster onset, longer period of analgesia and superior quality of 
anaesthesia.
SPECIFIC NARCOTIC ANTAGONIST:
Naloxone 1-4 μg/Kg IV 
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SPREAD OF OPIOIDS IN THE CEREBROSPINAL FLUID
                       
 Opioids that are injected into the lumbar intrathecal space exert their 
analgesic effect by activation of spinal opioid receptors located in the 
substantia gelatinosa of the dorsal horn.
In addition, they can spread upward through the passive flow of 
cerebrospinal fluid to reach the vasomotor, respiratory and vomiting centers 
of the brain.
The rostral spread of intrathecal opioids is thought to be responsible 
for unwanted effects such as respiratory depression, hypotension, nausea and 
vomiting.
Systemic absorption and redistribution to the brain is an alternative 
route for activating brain-stem opioid receptors that may account for early 
side effects, whereas rostral spread within the cerebrospinal fluid may be 
responsible for late side effects.
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HISTORY AND REVIEW OF LITERATURE
History of Subarachnoid block
In 1885, James Leonard Corning, a New York neurologist first used 
cocaine experimentally in dogs. In man, the first spinal anaesthesia was 
conducted by August Bier on 16th august 1898 with cocaine 3ml as 0.5% 
solution.
It was soon followed by Rudolf Matas in America and Tuffier in 
France.
Bupivacaine
Bupivacaine was synthesized in Sweden by Ekenstam and his 
colleagues in 1957 and was first used clinically by L.J. Telivuo in 1963.
Intrathecal Opioids
Gate control theory of pain (1965) by Melzack and Wall focused the 
attention on importance of dorsal horn of spinal cord in the modulation of 
pain.
In 1973, Pert and Snyder identified the specific opiate receptors in the 
substantia gelatinosa of dorsal horn of spinal cord.
In 1976, spinal effects of intrathecal opiates in animals were 
demonstrated by Yaksh and Rudy
In 1977, Wang, Naurs and Thomas studied the effects of intrathecal 
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morphine in men with intractable pain of lower limb due to malignancy 
invading the lumbosacral plexus.
In 1980, Davier et al, identified that respiratory depression with 
intrathecal morphine could be reversed with low dose naloxone, without 
reversing the analgesia.
In 1981, Yaksh and Rudy described the action of intrathecal pethidine 
and morphine in primates by ionotophoretic administration of the drugs into 
the substantia gelatinosa. They found out high level of opiate binding in 
substantia gelatinosa indicating the presynaptic action of opiate. Spinal 
opiates also seemed to cause significant elevation of nociceptive threshold.
In 1988, Inagaki Y, Takeyama E studied the efficacy of post operative 
pain relief after the use of intrathecal buprenorphine with local anesthetic 
agent and found it to prolong the post operative analgesia.
Spinal opioids and labour analgesia
Opiates have been used as analgesic agents in obstetrics since the 
Babylonians discovered their pain relieving properties.
Subarachnoid block was first used for obstetric delivery in 1901 by 
Kreis in Germany
Articles quoting the use of Intrathecal pethidine in labour and delivery 
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were reported in British Journal of anaesthesia in 1987.
Morphine was the first opioid to be used intrathecally but has the 
limitations of long latency, high incidence of maternal side effects, poor 
perineal analgesia and delayed respiratory depression. (Alper M, intrathecal 
morphine; a new method of obstetric analgesia, Anesthesiology, 1979: 51; 
378-379).
Sufentanil and intrathecal anaesthesia
The increased availability of lipid soluble opioids with shorter latency 
and demonstration of synergistic effects of opioids when combined with 
local anaesthetic have led to the widespread use of neuraxial opioids in 
labour.
The effect of lipophilic agents are better when administered at the 
level at which analgesia is required. Commonly used opioids are meperidine, 
fentanyl and sufentanil. (Honet JE, Arkoosh VA, Norris MC et 
al.Comparison among intrathecal fentanyl, meperidine and sufentanil for 
labour analgesia. Anaesthesia Analgesia 1992:75:734-739) 
Justins et al 1982: the dose of local anesthetic required for labour pain relief 
can be diminished to one half to one third with the addition of intrathecal 
opioids and provides excellent analgesia for the entirety of labour.
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Dahlgren, Gunnar et al 1997: compared the effects of intrathecal 
sufentanil 2.5 and 5 μg, fentanyl 10μg, and placebo when administered 
together with hyperbaric bupivacaine 0.5%, 12.5mg for caesarean section. 
They demonstrated that small doses of fentanyl or sufentanil (synthetic 
opioids) added to bupivacaine (local anesthetic) for spinal anesthesia for 
caesarean section reduced the need for intraoperative antiemetic medication 
and increased the duration of analgesia in the early post operative period 
compared with placebo.
Michael J. Cousins and Lawrence E. Motler, intrathecal and epidural 
administration of opioids, Anaesthesiology, 1992; 61 : 276-310.
Robert K. Stoelting, Pharmacology and Physiology in Anaesthetic 
practice, 3rd edition.
Thomas E.J. Healy ; Wylie and Churchill Davidson’s, A practice of 
anaesthesia 7th edition; 1995
LE  BARS  et al  in  1976, and  JURN  and  HEINZ in 1979 
demonstrated that in electrophysiological terms , it is “C” and “A delta” 
fiber’s  primary afferent input to wide dynamic range cells in spinal cord 
which appear to be most sensitive to the intrathecally applied morphine. The 
selectivity may be due to inhibtion of temporal facilitation.
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In 1977, WANG, NAUSS and THOMAS studied the effect of 
intrathecal morphine in man in intractable pain of back and leg due to 
malignancy, invading lumbosacral plexus. Predictable relief of pain was 
achieved without motor or sensory block.
In 1980, DAVIES et al, identified respiratory depression after 
intrathecal morphine, reversed with systemic Naloxone, without reversing 
analgesia in 3 out of 6 patients.
In July 1998, NGIAM SK, CHONG JL compared the effects of 
intrathecal fentanyl 15 mcg added to 7.5 mg of bupivacaine, 10 mcg of 
sufentanil added to 7.5 mg of bupivacaine and 7.5 mg of bupivacaine alone 
in 60 ASA І&ІІ patients coming for elective cesarean section. They found 
that the duration of effective analgesia of bupivacaine alone was prolonged 
with the addition of sufentanil and fentanyl by 358% and 256% respectively. 
None of the patients required additional intraoperative analgesia.
In 1999, KENNETH H. GWIRTZ M.D,JERRY V.YOUNG M.D et al 
belonging to Indiana  University School of Medicine,Indianapolis,Indiana 
studied the safety and efficacy of intrathecal opioid analgesia for acute 
postoperative pain.
In June 1999,R.FOURNIER,M.D., E. VAN 
GESSEL,M.D.,A.WEBER M.D., Z.GAMULIN M.D., compared the effects 
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of intrathecally administered sufentanil 7.5mcg and fentanyl 40mcg for 
postoperative pain relief after total hip replacement. They concluded that 
both the groups had rapid and profound pain relief with comparable onset 
and duration of action.   
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MATERIALS AND METHODS
After getting the approval from the ethical committee of the 
Department of Anesthesiology, Government Rajaji Hospital attached to 
Madurai Medical College, Madurai, the study was conducted in 80 patients 
undergoing elective and emergency caesarean section after getting consent 
and explaining the procedure details to the patients.
Exclusion criteria
Term parturients aged 18 to 35 years classified under ASA physical 
status I and II, IE and IIE who were termed fit for subarachnoid block were 
selected. Patients with coexisting medical diseases were excluded. Patients 
who were converted to general anaesthesia were excluded later.
Preoperative preparation
After preoperative assessment, the pregnant patients were 
premedicated with 
Inj. Metaclopromaide 10mg
Inj. Ranitidine 50mg – intramuscularly 45 minutes before 
induction of anaesthesia
52
Patients were randomly allotted into two groups.
GROUP I: Inj bupivacaine (0.5%) heavy 1.5cc + 0.1cc of 
normal saline
GROUP II:   Inj bupivacaine (0.5%) heavy 1.5cc +sufentanil 
5μg
Procedure details
In the preoperative visit, patients were explained of the procedure 
details.
Then baseline preoperative pulse rate and blood pressure were 
recorded. Intravenous life line was started with 18G cannula.
All patients were preloaded with 15-20ml/Kg of normal saline/ ringer 
lactate.
Following emergency drugs and equipments were kept ready before 
anaesthetic intervention. 
1. Boyle’s apparatus
2. Continuous flow - oxygen source
3. Laryngoscope with all size blades
4. Airway – all sizes
5. Suction apparatus
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6. Drugs – ephedrine, dopamine, atropine, adrenaline
7. Naloxone
Patients were put in lateral position and with strict aseptic precautions 
lumbar puncture was done with Quincke Babcock’s standard spinal needle – 
23 G.
After ensuring free flow of cerebrospinal fluid, the drug was injected 
as per the group assigned.
The assigned amount of sufentanil and normal saline were taken in 
sterile tuberculin syringe.
After injection patient was put up in supine position with left lateral 
tilt and 100% oxygen given through Magill’s breathing circuit until delivery 
of the baby.
Recording of data
Time of subarachnoid injection.
Hemodynamics
Blood pressure, pulse rate, respiratory rate were monitored every 2 
minutes for first 10 minutes and every 5 minutes till end of surgery.
Time of starting of the surgery
Any discomfort during visceral handling was noted
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Hypotension is said to have occurred if there was 20% fall from 
baseline blood pressure. The treatment includes 100% oxygen, intravenous 
fluids and ephedrine in incremental dose.
Bradycardia
It was treated with inj. Atropine 0.6mg intravenously.
Nausea and vomiting
It was treated with inj. Metaclopromide 10mg intravenously.
Pruritus
It was treated with diphenhydramine 25mg intravenously.
Two segment regression time
Time taken to decrease from maximal initial sensory level by two 
segments from the initial level is noted.
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Sedation score
Brain and Ready’s sedation score was employed
1. Fully awake
2. Drowsy
3. sleeping but arousable
4. arousable to painful stimulus
5. Not able to awake
Foetal outcome
After delivery, fetal outcome was assessed with Apgar score 
calculated at 1 minute and 5 minutes. Reflexes like sucking, rooting and 
moro’s were tested and recorded.
Total duration of analgesia
In the post operative period total duration of analgesia was taken as 
that period from the time of induction (subarachnoid block) till patient’s first 
requirement for analgesic medication.
Pain was evaluated using linear Visual Analogue Scale (VAS).
VAS           0- no pain
                  10- Worst pain
                   If VAS score was more than 6, supplementary analgesia was 
given and the study concluded.
Also in the post operative period every mother and baby were 
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followed up for any complication like respiratory depression, postoperative 
nausea and vomiting, pruritus, urinary retention and hypotension. 
Statistical significance was brought out by Student’s t – test.
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OBSERVATION AND RESULTS
In this randomized single blinded study, conducted in 80 patients, the 
subjects were allocated into 2 groups
GROUP I: Inj bupivacaine (0.5%) heavy 1.5cc + 0.1cc of 
normal saline
GROUP II:   Inj bupivacaine (0.5%) heavy 1.5cc +sufentanil 
5μg.
DEMOGRAPHIC DATA
 Both groups were comparable in age, height and duration and nature 
of surgery
Age      
AGE ( IN YEARS 
) GROUP I GROUP II
MINIMUM 20 20
MAXIMUM 34 42
MEAN 24.97 25.825
STANDARD 
DEVIATION 3.133 5.032
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           There was no statistically significant variation in age of the patients in 
both the groups.
            Both the groups were comparable.
Height
HEIGHT ( IN 
CENTIMETERS )
GROUP I GROUP II
MINIMUM 133 136
MAXIMUM 160 162
MEAN 151.22 153.67
STANDARD 
DEVIATION
5.90 5.91
                        There was no statistically significant variation in height of the 
patients in both the groups.
Both the groups were comparable.
Maximal level of sensory blockade
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SENSORY 
LEVEL
GROUP I GROUP II
T2 - 7
T3 - 1
T4 10 22
T5 1 1
T6 22 9
T7 1 -
T8 5 -
T9 - -
T10 2 -
Maximal sensory level achieved for pin prick sensation T6 in Group I 
and T4 in Group II
Highest level of blockade achieved was T4 in Group I&T2 in Group 
II.
Lowest level of blockade achieved was T10 in Group I and T6 in 
Group II. 
A significant variation noted in maximal level of sensory blockade in 
both the groups.
Two segment regression time
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TWO SEGMENT REGRESSION TIME
(MINUTES )
GROUP I GROUP II
MINIMUM 30 45
MAXIMUM 65 90
MEAN 44.75 64.25
STANDARD DEVIATION 10.12 13.51
Two segment regression time duration of analgesia as measured by 
two segment regression time were 44.75min in Group I with standard 
deviation of 10.12, 64.25min in group II with standard deviation of 13.51.
A significant variation noted in two segment regression time in both 
the groups.
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Total duration of analgesia
Total duration of analgesia was 76.5 minutes in group I with standard 
deviation of 19.12 (Around one hour and fifteen minutes)
150.37 minutes in group II with a standard deviation of 25.5, (Around 
two hour and thirty minutes).
Complications
SIDE EFFECTS GROUP I GROUP II
HYPOTENSION 2 7
NAUSEA & VOMITING - 6
RESPIRATORY DEPRESSION - -
PRURITUS - 16
BRADYCARDIA - 2
URINARY RETENTION - -
DISCOMFORT 21 -
SEDATIION - 2
Hemodynamic variable
With regard to blood pressure, a fall in blood pressure more 
than 20% from the baseline value was considered hypotension.
In Group I, 5% of patients had hypotension.
In Group II, 17, 5 % of patients had hypotension.
The hypotension in the study group required either intravenous 
fluids or injection ephedrine and oxygen supplementation.
None of them required any further intervention.
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With regard to pulse rate, a fall in pulse rate below 60 per 
minute was considered bradycardia.
About 5% of patients had bradycardia in Group II and it was treated 
with inj. Atropine 0.6 mg intravenously. None of them required any 
further intervention.
No bradycardia noted in Group I patients.
Sedation
Intraoperative sedation was excellent in Group II patients.
In Group II  
47.5 %of patients had sedation score of 2.
2.5% of patients had sedation score of 3.
In Group I
All patients had sedation score of 1.
Nausea and vomiting
In Group II 
15% of patients had nausea and vomiting.
Eventually all responded to Inj.metaclopromaide 10mg 
intravenously.
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In group I 
No patients had nausea or vomiting.
Pruritus
In Group II 
40% of patients had pruritus.
All responded to inj. Diphenhydramine.
In group I 
No patient had pruritus
Respiratory depression and urinary retention
No respiratory depression and urinary retention was noted in both the 
groups.
Intraoperative discomfort
In group II 100% of the patients were comfortable.
In group I 52.5% of the patients had intraoperative discomfort.
We had to necessarily manage them with analgesics and 
intravenous anaesthetics.
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Fetal outcome
Apgar was calculated at 1 minute and 5 minutes after deliver of 
baby. There was no neonatal respiratory depression noted. Apgar score was 
comparable in both the group.
It did not show statistically significant variation among the two 
groups. 
The score was 6.9 ±0.659 at the 1st minute and 8.725 ± 0.75 at the 5th 
minute in the sufentanil group.
The score was 7.22 ± 0.65at the1st minute and 8.95 ± 0.75 at the 5th 
minute in the control group.
None of the babies had any further neurological complications.
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DISCUSSSION
80 patients undergoing caesarean section with the physical status of 
ASA I, II, IE & IIE   were taken up for the study. They were randomly 
allocated into two groups, 40 patients in each group. Variables like age, 
height were standardized in both groups.
Group I (control group) received 1.5 cc of 0.5% bupivacaine with 0.1 
ml of normal saline intrathecally.
Group II (study group) received 1.5 cc of 0.5 % bupivacaine with 5 μg 
of sufentanil intrathecally.
Anaesthetic variables
Intra-operative study
In this study a lower dose of bupivacaine is used. We used 1.5ml of 
hyperbaric bupivacaine with 0.1 ml (5 μg) of sufentanil making a total 
volume of 1.6 ml to assess the quality of anaesthesia.
The quality of intra operative surgical anaesthesia was excellent in 
(100 %) of patients in sufentanil group as compared to 47.5 % in control 
group. All the patients who received 1.5ml of hyperbaric bupivacaine with 
sufentanil were comfortable during the intra operative period.
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About 52.5% of the patients who received bupivacaine alone had 
intraoperative discomfort significantly. They had to be necessarily 
maintained with adjuvant analgesic or intravenous anaesthetics
Addition of opioids aid in relieving the discomfort that could be 
caused by visceral handling. This is well brought out in other studies done 
by Peach. M.J. et al in 1994 & M.S. Batra et al.
Total duration of analgesia
The total duration of analgesia evaluated was significantly prolonged 
in sufentanil group; 150.38± 25.5 minutes compared to 76.5±19.12 minutes 
in control group
The requirement for the first dose of analgesia was significantly prolonged 
in sufentanil group.
This value was statistically significant as calculated by student's t-test. 
(p<0.001) 
The results of our study goes in consistent with the study by Braga 
Ade F,Braga F.S.et al at School of Medical Sciences,Campinas,Sao 
Paolo,Brazil.(Eur.J.Anaesthesiol.2003 Aug;20(8):631-5)
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2-segment regression time
2-segment regression of anesthesia took longer; 64.25±13.52 min in 
sufentanil group as compared with 44.75±10.12 in control group. This was 
proved statistically significant.
This value was statistically significant as calculated by student's t-test. 
(p<0.001)
Hemodynamic variables
The incidence of hypotension was about 17.5% in the study group 
compared with 5% in control group.
The hemodynamics after 5 minutes was 93.5±16.41 mm of Hg in 
sufentanil as compared with 101.75±18.5 in control group.
Opioids produce nausea and vomiting by direct stimulation of 
chemoreceptor trigger zone. This effect is dose related and can be treated 
with anticholinergic or phenothiazines, those are antagonistic at dopamine 
receptor. Route of opioid administration does not influence the occurrence of 
vomiting.
The incidence of vomiting in our study is 15%.
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Pruritus
This is a common side effect especially with obstetric population. 
Incidence from previous studies showed result of 0-100%.
This effect is dose dependent as shown by GilMcmorland, 1990, 
(personal communication), this effect is centrally mediated due to cephalad 
migration of the opioid to brain stem and fourth ventricle
It is self limiting, can also be antagonized by anti-histamines. .No 
patients required treatment in our study. 
40% of patients in our study had pruritus, which was dose related.
Consistent with the study conducted by Braga Ade et al concluded 
pruritus was the most common side effect  and had the significantly higher 
incidence when a dose of sufentanil 7.5mic was used(Eur J 
Anaesthesiol.2003 Aug;20(8):631-5)  
Sedation
Intra operative sedation was excellent in sufentanil group. 
In Control Group patients required sedative supplementation whereas 
no sedation was required in the sufentanil group.
About 47.5 % had sedation score of 2& 2.5% had sedation score of 3.
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Fetal outcome
Apgar was calculated at 1 minute and 5 minutes after deliver of baby. 
There was no neonatal respiratory depression noted. Apgar score was 
comparable in both the group.
It did not show statistically significant variation among the two 
groups. 
The score was 6.9±0.659 at the1st minute and 8.725±0.75 at the 5th 
minute in the sufentanil group.
The score was7.22±0.65at the1st minute and 8.95±0.75 at the 5th 
minute in the control group.
None of the babies had any further neurological complications.
So far varied numbers of studies have been conducted showing the 
efficacy of sufentanil in providing comfortable intraoperative period and 
prolonged post operative pain relief with minimal complication.
This study delineates that the acceptable dose range without much 
morbidity in hospitals with moderate post operative care and without high 
dependency unit with 5 μg of sufentanil Intrathecally.
It has been found out by this study that 5μg of Intrathecal sufentanil 
with 1.5ml of 0.5% hyperbaric bupivacaine provides
An improved quality of intraoperative surgical anesthesia.
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Increase in the duration of two segment regressions (64.25 ± 13.51).
Increase in the total duration of analgesia (150.375 ± 25.50).
The occurrence and intensity of side effects were so minimal and not 
significant. The benefit associated with administration of intrathecal 
sufentanil in a dose of 5μg outweighs the disadvantages of it.
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CONCLUSION
It has been found out by this study that addition of 5μg of sufentanil to 
low dose (7.5mg) of 0.5% of bupivacaine intrathecally in caesarean 
section provides improved quality of surgical anaesthesia and 
analgesia without significantly increasing maternal and fetal side 
effects than using bupivacaine alone.
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                                                      PROFORMA
                                                                                              Study / control
Case no. Date 
Name : Age/sex: I.P. NO: Ht: Wt:
Unit: ASA:
Patient pre operative condition Vital signs
Blood investigation: Pulse rate:
Hb %: BP: 
Blood sugar: CVS:
Sr. creatinine RS:
Premedication : inj. Ranitidine 50mg                                               Time of injection
                          Inj.  i.m Metaclopromide 10mg  i.m
PARAMETERS STUDIED
1. Time of intrathecal injection
2. Highest level of sensory block achieved (pinprick)
3. Intraoperative discomfort – yes / no 
4. Level of block at the end of surgery
5. Two segment regression time
6. Duration of post operative analgesia
7. VAS
0 Hr 1Hr 2 Hr 3 Hr 4 Hr 5 Hr
8. APGAR
               Sign                                      Score
0 1 minute 5 minutes
Heart rate Absent <100/ min >100/min
Respiratory effort Absent Slow, irregular Good,crying
Color Blue, pale Body pink, 
extremities blue
Completely 
pink
Reflex irritability 
(response to insertion of 
nasal catheter )
Absent Grimace Cough, sneeze
Muscle tone Limp Some flexion of 
extremities
Active motion
79
9. Hypotension ( .30% fall from base line BP )                     -  yes / no 
10. bradycardua (<60/min)                                                       - yes / no 
11. incomplete sensory block                                                   -  yes / no  
12. pruritus                                                                               -   yes / no
13. nausea & vomiting                                                              -  yes / no 
14. any complications for the baby                                          - yes / no
Intra operative monitoring
time Sensory 
level
PR BP Sedation 
score
Remarks
 
Sedation score
1. Fully awake
2. Drowsy
3. sleeping but arousable
4. arousable to painful stimulus
5. Not able to awake
VAS
• 0-1  excellent
• 2-4 good
• 5-6 fair
• 7-8 poor
• 9-10 no pain relief

